The analysis of lipids in biological systems, also known as lipidomics, is an incredibly diverse area of research, with wide-reaching consequences, from the understanding of cell signalling to unravelling the complexities of diseases, such as cancer or neurodegenerative disorders. Chromatography plays a key role in lipidomic analysis, with three main approaches emerging in the form of separation coupled to mass spectrometry (MS), direct infusion of the sample to MS (shotgun), and desorption ionization techniques coupled to MS. The separation prior to MS is generally performed using either gas chromatography (GC) or liquid chromatography (LC), but both techniques have their limitations and strengths. In the case of GC, the necessity of derivatization, and in LC the characteristic polarity ranges depending on the separation mode. However, researchers from the University of Pardubice, in Pardubice, Czech Republic, believe a third technique, which combines the advantages of GC and LC, is worth consideration and have recently published a paper making the case (1).
Known since the 1980s, supercritical fluid chromatography (SFC) uses a supercritical fluid as the mobile phase. The physicochemical properties of the supercritical fluids lead to low back pressures, allowing the use of high flow rates and good solubility properties when used as the mobile phase. However, SFC has struggled over the years to gain acceptance because of instrumental issues in the early stages of its development. However, modern ultrahigh-performance supercritical fluid chromatography (UHPSFC) systems now offer stable and reproducible results and the researchers believe the technique can be utilized effectively across the ‘omics' fields.
“The reproducibility was a problem in the past for SFC, and for me, this is the main aspect why now SFC can reach the level where the full potential of this methodology can be explored and used by researchers worldwide,” said Michal Holčapeck. “The advantages of UHPSFC–MS over ultrahigh‑pressure liquid chromatography (UHPLC)–MS are based on the physicochemical properties of the supercritical fluid or eventual subcritical fluid, which is often the case in real operating conditions. The polarity of supercritical carbon dioxide as the most prevailing SFC solvent is comparable to that of hexane and, therefore, the method is perfectly suited for all nonpolar molecules. This results in an outstanding sensitivity for nonpolar molecules. The speed of analysis is a highly appreciated feature, especially for high-throughput analysis. The van Deemter curves for UHPSFC and UHPLC clearly explain why we can increase the flow rate without loss of performance and with reduced risk of system overpressure. Moreover, there is still space for improvement when the pressure limit of current systems is increased. In some cases, UHPSFC offers different selectivities, which may be an example of ultrafast chiral separations of some pharmaceutical compounds.”
For those considering using UHPSFC–MS, the researchers believe the methodological switch from UHPLC–MS is not too difficult, as both techniques are very similar, plus the potential benefits, especially for nonpolar lipid classes as well as polar phospholipids and sphingolipids, are well worth consideration.
“I think that the methodology itself is ready to be immediately adopted by the wider research community,” continued Holčapeck.
The robustness and high-throughput of UHPSFC–MS potentially makes it ideal for routine clinical laboratories with thousands of samples; despite its past difficulties, SFC could be worth a second consideration.
Reference
New Study Uses MSPE with GC–MS to Analyze PFCAs in Water
January 20th 2025Scientists from the China University of Sciences combined magnetic solid-phase extraction (MSPE) with gas chromatography–mass spectrometry (GC–MS) to analyze perfluoro carboxylic acids (PFCAs) in different water environments.
The Next Frontier for Mass Spectrometry: Maximizing Ion Utilization
January 20th 2025In this podcast, Daniel DeBord, CTO of MOBILion Systems, describes a new high resolution mass spectrometry approach that promises to increase speed and sensitivity in omics applications. MOBILion recently introduced the PAMAF mode of operation, which stands for parallel accumulation with mobility aligned fragmentation. It substantially increases the fraction of ion used for mass spectrometry analysis by replacing the functionality of the quadrupole with high resolution ion mobility. Listen to learn more about this exciting new development.
A Guide To Finding the Ideal Syringe and Needle
January 20th 2025Hamilton has produced a series of reference guides to assist science professionals in finding the best-suited products and configurations for their applications. The Syringe and Needle Reference Guide provides detailed information on Hamilton Company’s full portfolio of syringes and needles. Everything from cleaning and preventative maintenance to individual part numbers are available for review. It also includes selection charts to help you choose between syringe terminations like cemented needles and luer tips.
The Complexity of Oligonucleotide Separations
January 9th 2025Peter Pellegrinelli, Applications Specialist at Advanced Materials Technology (AMT) explains the complexity of oligonucleotide separations due to the unique chemical properties of these molecules. Issues such as varying length, sequence complexity, and hydrophilic-hydrophobic characteristics make efficient separations difficult. Separation scientists are addressing these challenges by modifying mobile phase compositions, using varying ion-pairing reagents, and exploring alternative separation modes like HILIC and ion-exchange chromatography. Due to these complexities, AMT has introduced the HALO® OLIGO column, which offers high-resolution, fast separations through its innovative Fused-Core® technology and high pH stability. Alongside explaining the new column, Peter looks to the future of these separations and what is next to come.
Oasis or Sand Dune? Isolation of Psychedelic Compounds
January 20th 2025Magic mushrooms, once taboo, have recently experienced a renaissance. This new awakening is partially due to new findings that indicate the effects of psilocybin, and its dephosphorylated cousin psilocin may produce long lasting results for patients who might be struggling with anxiety, depression, alcohol and drug abuse, and post-traumatic stress disorder. Hamilton Company has developed a methodology for the isolation and identification of 5 common psychedelic compounds used in the potential treatment of disease. The PRP-1 HPLC column resin remains stable in the harsh alkaline conditions ideal for better separations.